# Enveric Biosciences, Inc.: Form 8-K, filed Feb 15, 2022

- Company: [Enveric Biosciences, Inc.](/companies/envb.md) (CIK 890821)
- Form: 8-K
- Filed: 2022-02-15
- Accepted by EDGAR: Feb 15, 2022, 11:07 ET
- Period: 2022-02-11
- Accession: 0001493152-22-004649
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/890821/000149315222004649/form8-k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/890821/000149315222004649/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/890821/000149315222004649/form8-k.htm

Filed Feb 15, 2022.
Source: SEC EDGAR, the filing index for accession 0001493152-22-004649. Last ingested by Listed: Nov 14, 2026, 20:02 ET. No prices; not investment advice.
